Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH) is a clinical research site located in New York, New York, United States 10029.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH) has participated in 7 clinical trials with 4 currently active.
Therapeutic areas: Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma.
Sponsors: Coherus Oncology, Inc., Tanabe Pharma America, Inc., AMAG Pharmaceuticals, Inc..
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH) has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH) has 7 clinical trials on record, with 4 currently active. Their work covers Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma.
Yes — Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH) holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.